The Study
Integrative Omics Reveal Female‐Specific Benefits of p16+ Cell Clearance in Aging Mice
This study looked at old mice and found that female mice had more 'old, tired' cells than males, and when scientists removed those cells, the female mice got stronger and their livers looked healthier. But it doesn't prove that removing the cells caused the improvement — it just shows they happened together.
Analysis score
Maximum 72 for a cohort study.
Where the score came from
As mice get old, some of their cells stop working right and start causing trouble — like tiny, angry neighbors. This study found that female mice get way more of these troublemaker cells than males, especially in the liver. When scientists removed them, female mice got stronger, healed faster, and their livers became healthier — but male mice didn’t improve.
Where does this study sit?
Reviews of RCTs (Meta-analyses)
Max 100Randomized Trials
Max 90Reviews of Cohort Studies
Max 85Cohort Studies
Max 72Reviews of Case-Control Studies
Max 63Case-Control Studies
Max 58Cross-Sectional & Case Series
Max 50Expert Opinion
Max 518 / 100
Quality score
Groups of people are followed over time to see who develops an outcome. Strong for identifying risk factors and associations, but cannot prove causation as firmly as RCTs.
Key takeaways
Summary
Based on the study abstract and findings.
- 1Yes — if similar effects occur in humans, this could mean anti-aging treatments might work much better for women than men, and we need to design them differently by sex.
- 2Female mice had 3x more troublemaker cells than males by age 23 months.
- 3After removal, grip strength improved significantly in females but not males; liver damage markers dropped 2x more in females.
Score breakdown, methodology, conflicts of interest, evidence analysis & raw study data
Publication
Journal
Advanced Science
Year
2025
Authors
Yao Lin, Boshi Wang, Meng-Wei Huang, J. Wolters, M. Demaria
Related Content
Claims (6)
Removing cells that express the p16 protein in mice results in better tissue function and longer life.
Removing p16-positive senescent cells in aged female mice changes liver gene activity to match patterns seen with calorie restriction, rapamycin, and acarbose, resulting in improved mitochondrial function and reduced inflammatory signals.
In older mice, females start with higher levels of inflammation markers linked to aging cells and show a larger decrease in these markers after removing cells expressing p16, compared to males.
In aged female mice, p16-positive senescent cells accumulate at higher levels in tissues such as the liver compared to aged male mice, and removing these cells improves grip strength, skin regeneration, and reduces liver damage only in females.
Removing p16-positive cells from aged female mice consistently increases activity in mitochondrial gene pathways and decreases activity in immune and inflammatory gene pathways, regardless of whether ganciclovir, ouabain, or miR-302b is used to remove the cells.
In aged female mice, removing cells that express p16 leads to increased activity of BMAL1 and ZEB2 transcription factors and decreased activity of JUN, BATF, and SPI1 transcription factors, resulting in reduced inflammation linked to cellular senescence.
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.